TITLE

Pegloticase Injection (KrystexxaTM)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
October 2010
SOURCE
Internal Medicine Alert;10/29/2010, Vol. 32 Issue 20, p158
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the Krystexxaâ„¢ pegloticase injection from Savient Pharmaceuticals Inc. which is intended for hyperuricemia treatment. It mentions the potential side effects of the injection such as anaphylaxis and infusion reactions. It explores the two randomized, placebo-controlled trials which revealed the injection's effectiveness. It adds that pegloticase serves as an alternative treatment for the hyperuricemia patients who did not respond to standard therapy.
ACCESSION #
56440536

 

Related Articles

  • Note interaction of oxandrolone, warfarin.  // Drug Topics;5/17/2004, Vol. 148 Issue 10, p8 

    Reports that the Savient Pharmaceuticals recently notified healthcare professionals of a drug interaction between oxandrolone USP and warfarin.

  • Cefmetazole.  // Reactions Weekly;2/24/2007, Issue 1140, p9 

    The article presents a case study on the adverse effect of intravenous (IN) cefmetazole injection on a 63-year-old woman with perianal Bowen's disease. After receiving the drug, the patient had anaphylactic shock. Her systolic blood pressure (BP) declined and edema and erythema developed on her...

  • Adverse reactions to intravenous induction agents.  // British Medical Journal;9/2/1978, Vol. 2 Issue 6138, p648 

    Examines the adverse effects to intravenous induction agents. Clinical features of the adverse reactions; Causes of the side effects; Incidence of reactions to induction agents.

  • Allopurinol.  // Reactions Weekly;1/15/2011, Issue 1334, p8 

    The article describes the case of a 33-year-old man who developed drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome while taking allopurinol for hyperuricaemia.

  • Temsirolimus.  // Reactions Weekly;Apr2014, Vol. 1497 Issue 1, p37 

    The article presents a case study of a 83-year-old man diagnosed with minor fatigue and occasional epistaxis developed while receiving temsirolimus.

  • Adverse event reports relating to Augmentin. Diesel, Gillian // Veterinary Record: Journal of the British Veterinary Association;6/6/2015, Vol. 176 Issue 23, p601 

    The article offers the author's insights on the increasing number of reports received by the Veterinary Medicines Directorate (VMD) on the adverse reactions of Augmentin Intravenous Powder for Solution for Injection.

  • Febuxostat.  // Reactions Weekly;5/18/2013, Issue 1453, p22 

    The article presents a case study of a 74-year-old woman and a 68-year-old man who experienced neutropenia while receiving febuxostat for hyperuricaemia treatment.

  • Allopurinol.  // Reactions Weekly;Feb2015, Vol. 1538 Issue 1, p17 

    The article presents a case study of a 41-year-old man who developed allopurinol hypersensitivity syndrome (AHS) while receiving allopurinol for asymptomatic hyperuricaemia.

  • Pegloticase-related serious AEs reported at ACR meeting.  // Reactions Weekly;11/8/2008, Issue 1227, p2 

    The article reports on the findings of the pegloticase clinical studies conducted by Savient Pharmaceuticals that were presented during the 2008 annual meeting of the American College of Rheumatology (ACR). There were two cardiac serious adverse events resulting in death that have been reported...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics